Gerry Beaney

Gerry is a consultant to growth companies seeking strategic advice or funding for expansion. He was a non-executive director of Spectral MD Holdings Ltd (subsequently renamed Spectral AI, Inc.) a medical technology company quoted on AIM between June 2021 and September 2023. He acted as chairman of the Nomination Committee and was a member of the audit committee. He was formerly chairman of the remuneration committee. Gerry stepped down from the board on the company’s admission to NASDAQ in September 2023. Prior to Spectral MD Holdings Ltd, he carried out senior executive roles in the corporate finance sector for over 25 years.

During 2018 he was the Chief Executive Officer of Northland Capital Partners Limited, an institutional stockbroker based in London. He acted as Northland’s Head of Corporate Finance between 2014 and 2018. From 1997 to 2013 he was a Partner and Head of Capital Markets at Grant Thornton UK LLP which grew to become the largest independent nominated adviser to AIM companies under his leadership.

Prior to 1997 Gerry held various roles with Grant Thornton in the UK and New York City. He is a member of the Institute of Chartered Accountants of Scotland and was a member of the American Institute of Certified
Public Accountants between 1991 and 2016. He holds a Bachelor of Accountancy Degree from the University of Glasgow.